Jeffrey S. Glenn - Director at Eiger BioPharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
EIGR
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jeffrey S. Glenn since 12 Feb 2025

Holdings reported by Jeffrey S. Glenn for Eiger BioPharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 182,355 $54,287 $0.2977 22 Dec 2022 Direct
Common Stock 151,064 $44,972 $0.2977 22 Dec 2022 By Eiger Group International, Inc.
Common Stock 5,000 $1,489 $0.2977 22 Dec 2022 By spouse
Common Stock 460 $137 $0.2977 22 Dec 2022 By son
Stock Option (Right to Buy) 28,000 01 Mar 2023 Direct Common Stock

Transactions reported by Jeffrey S. Glenn for Eiger BioPharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.